Stocks: Wednesday's review

Japan’s Nikkei 225 Stock Average gained for an eighth day, extending its longest winning streak in 18 months, after the yen weakened and as brokerages raised investment recommendations on some companies.

Sumitomo Mitsui Financial Group Inc., Japan’s 2nd-largest bank by market value, climbed 2.3 percent after Nomura Holdings Inc. said the nation’s economy will rebound sooner than expected. Sony Corp., Japan’s biggest exporter of consumer electronics, advanced 2.6 percent. Toshiba Corp., a nuclear power-plant maker, and Asahi Glass Co. advanced at least 2.2 percent after brokerages increased their ratings on the companies.

European stocks rose for a fourth day, pushing the Stoxx Europe 600 Index to a 2 1/2-year high, as earnings from Heineken NV and Societe Generale SA beat estimates and U.S. housing starts topped forecasts.

Heineken, the world’s third-largest brewer, and Societe Generale, France’s second-biggest lender, rallied more than 3 percent. Sanofi-Aventis SA climbed 3.5 percent after agreeing to buy Genzyme Corp. for at least $20.1 billion. Clariant AG sank the most in eight years after saying it will acquire Sued-Chemie AG in a deal valued at 2 billion euros ($2.7 billion).

U.S. stocks gained Wednesday, propelled by a $20 billion merger in the pharmaceutical sector and a batch of solid corporate earnings.

The S&P 500 (SPX) added 8 points, or 0.6%, to 1,336.40, more than doubling its financial meltdown low of 666.79 on March 6, 2009.

Family Dollar (FDO, Fortune 500) rallied 10% after the discount retailer said it received an unsolicited offer from Nelson Peltz's Trian Group, making it the biggest gainer on the S&P 500.

The Nasdaq (COMP) rose 24 points, or 0.9%, led by a 13% jump in shares of Dell (DELL, Fortune 500), which delivered a stellar fourth-quarter profit. Comcast (CMCSA, Fortune 500) was also a strong performer on the tech-heavy index, with the cable TV provider jumping 5% after reporting better-than-expected quarterly results.

Investors were also cheering the latest big M&A deal. French drugmaker Sanofi-aventis agreed to buy Genzyme, a Massachusetts-based biotech company, for $20.1 billion in cash. The deal was announced before the opening bell. Sanofi (SNY) shares rose 1%, while Genzyme (GENZ, Fortune 500)'s stock increased 1.3%.

Economy: A government report showed the number of housing starts rose more than expected in January, while permits for new construction were weaker than forecast.

Housing starts rose 14% to an annual rate of 596,000 units last month, while building permits, considered a leading indicator of activity, fell 10% to an annual rate of 562,000 in January.

Minutes from the most recent meeting of the Federal Reserve released Wednesday showed that policymakers anticipate a bigger bump in economic growth for 2011 than they thought just a few months ago. But the Fed said the acceleration in growth will mainly be limited to the short term, as growth estimates for 2012 and 2013 were only slightly adjusted.

Latest news

23.04.2024

Mexican Peso soars against US Dollar as US business activity slows down

23.04.2024

Canadian Dollar recovers further ground after US PMIs bolster rate cut hopes

23.04.2024

US Dollar dips following disappointing S&P PMI figures

23.04.2024

GBP/USD Price Analysis: Bulls stepped in as ‘morning star’ chart pattern looms

23.04.2024

USD/CHF Price Analysis: Faces selling pressure above 0.9100 after weak US PMI

23.04.2024

Silver Price Analysis: Silver price in steep sell-off after touching top of four-year range

23.04.2024

AUD/USD Price Analysis: Despite signs this is probably not a bullish reversal

23.04.2024

ECB's Nagel: Need to be convinced inflation is heading back to target before cutting rates

Support

Personal area

Trading
- Account types
- Market
- MetaTrader 4/5
Promotions
- Promotions
Investments
- Synchronous Trading
  - Rating
  - About Service
  - How it Works
  - FAQ
Analytics
- News and Tools
- Market analysis
  - Market Opinions
  - Technical Analysis
TeleTrade
- About brand
- Сooperation

Personal area

Forex Demo Account

Start Bonus 100%

Synchronous Trading

Our Advantages

Economic Calendar

This site is managed by Teletrade D.J. LLC 2351 LLC 2022 (Euro House, Richmond Hill Road, Kingstown, VC0100, St. Vincent and the Grenadines).

The information on this website is for informational purposes only and does not constitute any investment advice.

The company does not serve or provide services to customers who are residents of the US, Canada, Iran, The Democratic People's Republic of Korea, Yemen and FATF blacklisted countries.

AML Website Summary

Risk Disclosure

Making transactions on financial markets with marginal financial instruments opens up wide possibilities and allows investors who are willing to take risks to earn high profits, carrying a potentially high risk of losses at the same time. Therefore you should responsibly approach the issue of choosing the appropriate investment strategy, taking the available resources into account, before starting trading.

Privacy Policy

Use of the information: full or partial use of materials from this website must always be referenced to TeleTrade as the source of information. Use of the materials on the Internet must be accompanied by a hyperlink to teletrade.org. Automatic import of materials and information from this website is prohibited.

Please contact our PR department if you have any questions or need assistance at pr@teletrade.global.

Bank
transfers